Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial

by Megan K. Yee, C. Michael Gibson, Tarek Nafee, Mathieu Kerneis, Yazan Daaboul, Serge Korjian, Gerald Chi, Fahad AlKhalfan, Adrian F. Hernandez, Russell D. Hull, Alexander T. Cohen, Samuel Z. Goldhaber
Published 2019-04-01

The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification

by C. Michael Gibson, Alex C. Spyropoulos, Alexander T. Cohen, Russell D. Hull, Samuel Z. Goldhaber, Roger D. Yusen, Adrian F. Hernandez, Serge Korjian, Yazan Daaboul, Alex Gold, Robert A. Harrington, Gerald Chi
Published 2017-06-01

Machine learning to predict venous thrombosis in acutely ill medical patients

by Tarek Nafee, C. Michael Gibson, Ryan Travis, Megan K. Yee, Mathieu Kerneis, Gerald Chi, Fahad AlKhalfan, Adrian F. Hernandez, Russell D. Hull, Ander T. Cohen, Robert A. Harrington, Samuel Z. Goldhaber
Published 2020-02-01

Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals

by Anne-Céline Martin MD, PhD, Wei Huang PhD, Samuel Z. Goldhaber MD, Russell D. Hull MD, Adrian F. Hernandez MD, Charles-Michael Gibson MD, Frederick A. Anderson PhD, Alexander T. Cohen MD
Published 2019-10-01